SUBSCRIBE
SUBSCRIBE
News   Policy

FDA Requests More Safety Data On Asthma Drugs

March 5, 2008 | 
1 min read

WASHINGTON (Reuters) - U.S. health officials said on Wednesday they had requested more information from GlaxoSmithKline Plc and other makers of certain asthma drugs to further analyze the safety of the medicines.

Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Red round circle with a pause button or icon against yellow background.
Gene therapy
Liver Toxicities Force Pause on Two Dose Groups of UniQure’s Mid-Stage Fabry Study
February 9, 2026
 · 
1 min read
 · 
Tristan Manalac
Magnifying glass focusing on number 2026 with target icon on yellow background. Concept for new year focus, business goals, trends, planning, strategy, vision, success, and future opportunities.
Opinion
2025 Reshaped the FDA. What Will 2026 Hold?
February 9, 2026
 · 
6 min read
 · 
Claire Davies
Digital compass. Business strategic explorer, Vision crisis, Mission path, Agency creative, Digital strategy, Market decision, Achievement strategy, Financial stock, Company vision concepts
Policy
FDA Policy Tracker 2026: Priority Vouchers Questioned, PRVs Return
February 9, 2026
 · 
5 min read
 · 
Heather McKenzie
Donald Trump signing an executive order
Drug pricing
TrumpRx Website Set To Launch Thursday Evening After Delay
February 5, 2026
 · 
1 min read
 · 
Dan Samorodnitsky